GSK Tests out Ambit s Profiling Technology

genomeweb
360dx

GSK Tests out Ambit s Profiling Technology

Mar 04, 2003

NEW YORK, March 4 - GlaxoSmithKline is evaluating Ambit Biosciences' screening technology to characterize small molecule kinase inhibitors, Ambit said today.

To read the full story....

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

3,000 Rice Genomes Project Sequences Reveal Asian Rice History, Diversity
Thermo Fisher Scientific Reports 23 Percent Revenue Growth in Q1
ABRF Speakers Describe Combining Sequencing With Other Approaches to Get More Data From Single Cells
Illumina Q1 2018 Revenues Rise 31 Percent
ABRF Single-Cell RNA-Seq Platform Comparison Finds Similar Performance, Drawbacks for Each
Sweet Wormwood Genome Provides Clues for Boosting Production of Antimalarial Compound

The Scan

Now You Can Read Them, Now You Can't

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

The Mouths of Heavy Drinkers Are Disgusting

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

For Health or For Fun?

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

This Week in Genome Research

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.

Main menu